Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global

1. Executive Summary
 
2. Global – Cancer Testing Market and New Cases
2.1 Global – Cancer Testing Market (2010 – 2018) 
2.2 Global – Number of New Cancer Cases (2009 – 2020) 
 
3. Global – Cancer Testing Market Share
3.1 Global – Segment Wise Cancer Testing Market Share& Forecast (2011 – 2018) 
3.2 Global – Organ Specific Cancer Testing Market Share & Forecast (2010 – 2018) 
 
4. Global – Segment Wise Cancer Testing Market
4.1 Prostate Specific Antigen (PSA) Test Market & Forecast (2010 – 2018) 
4.2 Fecal Occult Blood Test Market & Forecast (2009 – 2018) 
4.3 Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast (2010 – 2018) 
4.4 Human PapillomaVirus (HPV) Test Market & Forecast (2010 – 2018) 
4.5 Bladder Test Market & Forecast (2010 – 2018) 
4.6 Serum Based Cancer Markers Market & Forecast (2008 – 2018) 
4.7 Pharmacognostic Histology Market & Forecast (2011 – 2018) 
4.8 Flow Cytometry  Market & Forecast (2011 – 2018) 
4.9 Other Test Market& Forecast (2011 – 2018) 
 
5. Global – Organ Specific Cancer Testing Market
5.1 Bladder Cancer Test Market& Forecast (2010 – 2018) 
5.2 Breast Cancer Test Market & Forecast (2010 – 2018) 
5.3 Cervical Cancer Test Market & Forecast (2010 – 2018) 
5.4 Colorectal (Colon) Cancer Test Market & Forecast (2010 – 2018) 
5.5 Ovarian Cancer Test Market & Forecast (2010 – 2018) 
5.6 Prostate Cancer Test Market & Forecast (2010 – 2018) 
5.7 Liver Cancer Test Market & Forecast (2010 – 2018) 
5.8 Other Organ Specific Cancer Test Market & Forecast (2010 – 2018) 
 
6. Cancer Diagnostics– Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis) 
6.1 Abbott
6.1.1 Abbott – Cancer Test Platforms
6.1.2 Abbott's Cancer Pipeline Analysis
 
6.2 Radient Pharmaceuticals
6.2.1 Radient Pharmaceuticals – Cancer Test Platforms
 
6.3 BD Diagnostics
6.3.1 BD Diagnostics – Cancer Test Platform
6.3.2 BD Diagnostics Pipeline Analysis
 
6.4 Beckman Coulter, Inc. 
6.4.1 Beckman Coulter, Inc. – Cancer Test platform
 
6.5 BioCurex
6.5.1 BioCurex – Cancer Test Platform
6.5.2 BioCurex – Pipeline Analysis
 
6.6 bioMerieux
6.6.1 bioMerieux – Cancer Test Platform
6.6.2 bioMérieux - Pipeline Analysis
 
6.7 Cepheid
6.7.1 Cepheid – Cancer Test Platform
6.7.2 Cepheid – Pipeline Analysis
 
6.8 CytoCore Inc. 
6.8.1 CytoCore Inc. – Cancer Test Platform
6.8.2 CytoCore Inc. –    Pipeline Analysis
 
6.9 DiagnoCure, Inc. 
6.9.1 DiagnoCure, Inc. – Cancer Test Platform
6.9.2 DiagnoCure Inc. – Pipeline Analysis
 
6.10 Gen-Probe, Inc. 
6.10.1 Gen-Probe, Inc. – Cancer Test Platform
 
6.11 Genomic Health Inc. 
6.11.1 Genomic Health Inc. – Cancer Test Platform
6.11.2 GenomicHealth, Inc. – Pipeline Analysis
 
6.12 QIAGEN Marseille (Earlier Ipsogen) 
6.12.1 QIAGEN Marseille – Cancer Test Platform
 
6.13 Myriad Genetics, Inc
6.13.1 Myriad Genetics, Inc – Cancer Test Platform
6.13.2 Myriad Genetics, Inc – Pipeline Analysis
 
6.14 Panacea Pharmaceuticals, Inc. 
6.14.1 Panacea Pharmaceuticals, Inc. – Cancer Test Platform
 
6.15 Qiagen
6.15.1 Qiagen – Cancer Test Platform
6.15.2 Qiagen – Pipeline Analysis
 
6.16 Siemens Heathcare Diagnostics
6.16.1 Siemens Heathcare Diagnostics – Cancer Test Platform
 
6.17 Roche
6.17.1 Roche – Cancer Test Platform
6.17.2 Roche – Pipeline Analysis
 
6.18 Ventana Medical Systems, Inc. 
6.18.1 Ventana Medical Systems, Inc. – Cancer Test Platform
 
6.19 TrovageneInc. 
6.19.1 Trovagene, Inc. – Cancer Test Platform
6.19.2 TrovageneInc. – Pipeline Analysis
 
6.20 Vermillion, Inc
6.20.1 Vermillion, Inc – Cancer Test Platform
 
7. Geographic Region – Number of New Cancer Cases
7.1 Africa – Number of New Cancer Cases & Forecast (2009 – 2020) 
7.2 Americas – Number of New Cancer Cases & Forecast (2009 – 2020) 
7.3 Asia – Number of New Cancer Cases & Forecast (2009 – 2020) 
7.4 Europe – Number of New Cancer Cases & Forecast (2009 – 2020) 
7.5 Oceania – Number of New Cancer Cases & Forecast (2009 – 2020) 
 
8. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials
8.1 Bladder Cancer Number of New Cases & Clinical Trials
8.1.1 Bladder Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
8.1.2 Bladder Cancer – Tests Being Studied in Clinical Trials
 
8.2 Brain Cancer Number of New Cases
8.2.1 Brain Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.3 Breast Cancer Number of New Cases
8.3.1 Breast Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.4 Cervix Cancer Number of New Cases & Clinical Trials
8.4.1 Cervix Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 
8.4.2 Cervical Cancer – Test Being Studied in Clinical Trials
 
8.5 Colorectal Cancer Number of New Cases & Clinical Trials
8.5.1 Colorectal Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
8.5.2 Colorectal Cancer – Test Being Studied in Clinical Trials
 
8.6 Corpus Cancer Number of New Cases
8.6.1 Corpus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.7 Hodgkin’s Lymphoma Number of New Cases
8.7.1 Hodgkin’s Lymphoma Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 
 
8.8 Kaposi Sarcoma Number of New Cases
8.8.1 Kaposi Sarcoma Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.9 Kidney Cancer Number of New Cases
8.9.1 Kidney Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.10 Larynx Cancer Number of New Cases
8.10.1 Larynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.11 Leukaemia Number of New Cases
8.11.1 Leukaemia Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.12 Liver Cancer Number of New Cases & Clinical Trials
8.12.1 Liver Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
8.12.2 Liver Cancer – Test Being Studied in Clinical Trials
 
8.13 Lung Cancer Number of New Cases
8.13.1 Lung Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.14 Melanoma Number of New Cases
8.14.1 Melanoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.15 Myeloma Number of New Cases
8.15.1 Myeloma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.16 Nasopharynx Number of New Cases
8.16.1 Nasopharynx Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.17 Non-Hodgkin Lymphoma Number of New Cases
8.17.1 Non-Hodgkin Lymphoma Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.18 Oesophagus Number of New Cases
8.18.1 Oesophagus Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.19 Oral Cavity Number of New Cases
8.19.1 Oral Cavity Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.20 Other Pharynx Number of New Cases
8.20.1 Other Pharynx Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.21 Ovary Cancer Number of New Cases & Clinical Trials
8.21.1 Ovary Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
8.21.2 Ovarian Cancer – Tests Being Studied In Clinical Trials
 
8.22 Pancreas Cancer Number of New Cases
8.22.1 Pancreas Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.23 Prostate Cancer Number of New Cases & Clinical Trials
8.23.1 Prostate Cancer Number of New Cases & Forecast – Geographic Distribution (2009 -2020) 
8.23.2 Prostate Cancer – Test Being Studied in Clinical Trials
 
8.24 Stomach Cancer Number of New Cases
8.24.1 Stomach Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.25 Testis Cancer Number of New Cases
8.25.1 Testis Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
 
8.26 Thyroid Cancer Number of New Cases
8.26.1 Thyroid Cancer Number of New Cases & Forecast – Geographic Distribution (2009 - 2020) 
8.27 Other Sites – Number of New Cases

Figure 2 1: Global – Cancer Test Market (Million US$), 2010 – 2012
Figure 2 2: Global – Forecast for Cancer Test Market (Million US$), 2013 – 2018
Figure 2 3: Global – Number of New Cancer Cases (Number), 2009 – 2012
Figure 2 4: Global – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
 
Figure 3 1: Global – Segment Wise Cancer Test Market Share (Percent), 2011 – 2012
Figure 3 2: Global – Forecast for Segment Wise Cancer Test Market Share (Percent), 2013 – 2018
Figure 3 3: Global – Organ Specific Cancer Testing Market Share (Percent), 2010 – 2012
Figure 3 4: Global – Forecast for Organ Specific Cancer Testing Market Share (Percent), 2013 – 2018
 
Figure 4 1: Global – PSA Test Market (Million US$), 2010 –2012
Figure 4 2: Global – Forecast for PSA Test Market (Million US$), 2013 –2018
Figure 4 3: Global – Fecal Occult Blood Test Market (Million US$), 2009 –2012
Figure 4 4: Global – Forecast for Occult Blood Test Market (Million US$), 2013 –2018
Figure 4 5: Global – FISH Test Market (Million US$), 2010 – 2012
Figure 4 6: Global – Forecast for FISH Test Market (Million US$), 2013 – 2018
Figure 4 7: Global – HPV Test Market (Million US$), 2010 – 2012
Figure 4 8: Global – Forecast for HPV Test Market (Million US$), 2013 – 2018
Figure 4 9: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012
Figure 4 10: Global – Forecast for Bladder Test Market (Million US$), 2013 – 2018
Figure 4 11: Global – Serum Based Cancer Markers Market (Million US$), 2008 – 2012
Figure 4 12: Global – Forecast for Serum Based Cancer Markers Market (Million US$), 2013 – 2018
Figure 4 13: Global – Pharmacognostic Histology Market (Million US$), 2011 – 2012
Figure 4 14: Global – Forecast for Pharmacognostic Histology Market (Million US$), 2013 – 2018
Figure 4 15: Global – Flow Cytometry Market (Million US$), 2011 – 2012
Figure 4 16: Global – Forecast for Flow Cytometry Market (Million US$), 2013 – 2018
Figure 4 17: Global – Other Test Market (Million US$), 2011 – 2012
Figure 4 18: Global – Forecast for Other Test Market (Million US$), 2013 – 2018
 
Figure 5 1: Global – Bladder Cancer Test Market (Million US$), 2010 – 2012
Figure 5 2: Global – Forecast for Bladder Cancer Test Market (Million US$), 2013 – 2018
Figure 5 3: Global – Breast Cancer Test Market (Million US$), 2010 – 2013
Figure 5 4: Global – Forecast for Breast Cancer Test Market (Million US$), 2013 – 2018
Figure 5 5: Global – Cervical Cancer Test Market (Million US$), 2010 – 2012
Figure 5 6: Global – Forecast for Cervical Cancer Test Market (Million US$), 2013 – 2018
Figure 5 7: Global – Colorectal (Colon) Cancer Test Market (Million US$), 2010 – 2012
Figure 5 8: Global – Forecast for Colorectal (Colon) Cancer Test Market (Million US$), 2013 – 2018
Figure 5 9: Global – Ovarian Cancer Test Market (Million US$), 2010 – 2012
Figure 5 10: Global – Forecast for Ovarian Cancer Test Market (Million US$), 2013 – 2018
Figure 5 11: Global – Prostate Cancer Test Market (Million US$), 2010 – 2012
Figure 5 12: Global – Forecast for Prostate Cancer Test Market (Million US$), 2013 – 2018
Figure 5 13: Global – Liver Cancer Test Market (Million US$), 2010 – 2012
Figure 5 14: Global – Forecast for Liver Cancer Test Market (Million US$), 2013 – 2018
Figure 5 15: Global – Other Organ Cancer Test Market (Million US$), 2010 – 2012
Figure 5 16: Global – Forecast for Other Organ Cancer Test Market (Million US$), 2013 – 2018
 
Figure 7 1: Africa –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 2: Africa – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 3: Americas –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 4: Americas – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 5: Asia –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 6: Asia – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 7: Europe – Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 8: Europe – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
Figure 7 9: Oceania –Number of New Cancer Cases (Number), 2009 – 2012
Figure 7 10: Oceania – Forecast for Number of New Cancer Cases (Number), 2013 – 2020
 
List of Tables:
 
Table 6 1: Effectiveness of Onko-Sure Within Different Cancer Types
Table 6 2: Beckman Coulter – Flow Cytometry Technology portfolio and Various Bundling Options
Table 6 3: Beckman Coulter – Hematology Test Product portfolio
Table 6 4: bioMérieux – Tumor Markers offerings for Various Cancer
 
Table 8 1: Bladder– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 2: Bladder– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 3: Brain– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 4: Brain– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 5: Breast – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 6: Breast– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 7: Cervix– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 8: Cervix– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 9: Colorectal– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 10: Colorectal– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 11: Corpus– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 12: Corpus– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 13: Hodgkin’s Lymphoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 14: Hodgkin’s Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 15: Kaposi Sarcoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 16: Kaposi Sarcoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 17: Kidney– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 18: Kidney– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 19: Larynx– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 20: Larynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 21: Leukaemia – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 22: Leukaemia– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 23: Liver – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 24: Liver– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 25: Lung – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 26: Lung– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 27: Melanoma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 28: Melanoma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 29: Myeloma– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 30: Myeloma– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 31: Nasopharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 32: Nasopharynx– Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 33: Non-Hodgkin Lymphoma – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 34: Non-Hodgkin Lymphoma – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 35: Oesophagus – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 36: Oesophagus – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 37: Oral Cavity– Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 38: Oral Cavity – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 39: Other Pharynx – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 40: Other Pharynx – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 41: Ovary – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 42: Ovary – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 43: Pancreas – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 44: Pancreas – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 45: Prostate – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 46: Prostate – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 47: Stomach – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 48: Stomach – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 49: Testis – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 50: Testis – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 51: Thyroid – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 52: Thyroid – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020
Table 8 53: Other Sites – Region Wise Number of New Cancer Cases (Number), 2009 – 2012
Table 8 54: Other Sites – Forecast for Region Wise Number of New Cancer Cases (Number), 2013 – 2020